This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Document Security Systems Announces Partnership With National Association Of Drug Diversion Investigators

ROCHESTER, N.Y., Oct. 22, 2013 /PRNewswire/ -- Document Security Systems, Inc. (NYSE MKT: DSS; "DSS"), a leading developer and integrator of secure cloud computing and security printing technologies, today announced a partnership with the National Association of Drug Diversion Investigators (NADDI) to help NADDI's members and consumers combat drug diversion and counterfeits.

NADDI is a non-profit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of prescription drug diversion.  NADDI's objective is to improve its members' ability to investigate and prosecute pharmaceutical drug diversion.

This partnership provides NADDI members access to DSS's AuthentiSuite technologies as part of an initiative to standardize prescription drug authentication for members and customers. NADDI members have never before had access to this type of authentication capability. The AuthentiSite technology can be employed as a tool for investigators or consumers who are looking to verify websites for prescription drug purchases and validate that pharmaceutical product information, lists of authorized suppliers, and other online information comes from the Brand Owner and not an unauthorized or fraudulent source.

AuthentiSite provides true website authentication from a smartphone application. The DSS team will create and distribute an AuthentiSite seal equipped with DSS patented AuthentiGuard ® Prism TM technology for NADDI and its members to implement on their websites.  Using the smartphone application, investigators and consumers alike can scan the seal to verify that a website represents a true, licensed reseller.

Robert Bzdick, President of DSS stated, "We are pleased to be working with NADDI, the nation's most prominent organization linking healthcare regulators, manufacturers and consumers, to offer its members access to our AuthentiSite technology in order to combat drug diversion. This partnership brings the powerhouse of AuthentiSuite technologies into the pharmaceutical world, while opening up future opportunities to build business relationships in this area."

DSS will be attending NADDI's 24 th Annual Conference on November 19 th - The Challenges of Prescription Drug Abuse, Diversion and Counterfeiting for the Community, Law Enforcement and Industry - The Issues and the Fight Back – to discuss the growing number of possibilities AuthentiSite offers.

Charlie Cichon, NADDI Executive Director stated, "We welcome the partnership with DSS and the extraordinary technology of AuthentiSuite, not only at our 24 th Annual Conference in St. Louis, but also through the RxAuthentic link that our members and consumers can access on the NADDI website –"


The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs